DOI QR코드

DOI QR Code

Transcatheter closure of small ductus arteriosus with amplatzer vascular plug

  • Cho, Eun Hyun (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Song, Jinyoung (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Kang, I-Seok (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Huh, June (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Lee, Sang Yoon (Department of Pediatrics, Sejong General Hospital) ;
  • Choi, Eun Young (Department of Pediatrics, Seoul National University Bundang Hospital) ;
  • Kim, Soo Jin (Department of Pediatrics, Konkuk University Medical Center)
  • Received : 2013.06.26
  • Accepted : 2013.08.05
  • Published : 2013.09.15

Abstract

Purpose: The purpose of this study was to share our experience of transcatheter closure of small patent ductus arteriosus (PDA) by using an Amplatzer vascular plug (AVP). Methods: We reviewed the medical records of 20 patients who underwent transcatheter closure at Samsung Medical Center and Sejong General Hospital from January 2008 to August 2012. The size and shape of the PDAs were evaluated by performing angiograms, and the PDA size and the AVP devices size were compared. Results: The mean age of the patients was $54.9{\pm}45.7$ months old. The PDAs were of type C (n=5), type D (n=12), and type E (n=3). The mean pulmonary end diameter of the PDA was $1.7{\pm}0.6$ mm, and the aortic end diameter was $3.6{\pm}1.4$ mm. The mean length was $7.3{\pm}1.8$ mm. We used 3 types of AVP devices: AVP I (n=5), AVP II (n=7), and AVP IV (n=8). The ratio of AVP size to the pulmonary end diameter was $3.37{\pm}1.64$, and AVP size/aortic end ratio was $1.72{\pm}0.97$. The aortic end diameter was significantly larger in those cases repaired with AVP II than in the others (P=0.002). The AVP size did not significantly correlate with the PDA size, but did correlate with smaller ratio of AVP size to aortic end diameter ($1.10{\pm}0.31$, P=0.032). Conclusion: Transcatheter closure of small PDA with AVP devices yielded satisfactory outcome. AVP II was equally effective with smaller size of device, compared to others.

Keywords

References

  1. Porstmann W, Wierny L, Warnke H, Gerstberger G, Romaniuk PA. Catheter closure of patent ductus arteriosus. 62 cases treated without thoracotomy. Radiol Clin North Am 1971;9:203-18.
  2. Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG, et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ${\leq}6$ kg. JACC Cardiovasc Interv 2010;3:1295-9. https://doi.org/10.1016/j.jcin.2010.08.022
  3. Hijazi ZM, Lloyd TR, Beekman RH 3rd, Geggel RL. Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing < or = 8 kg: retrograde versus antegrade approach. Am Heart J 1996;132:827-35. https://doi.org/10.1016/S0002-8703(96)90318-X
  4. Park YA, Kim NK, Park SJ, Yun BS, Choi JY, Sul JH. Clinical outcome of transcatheter closure of patent ductus arteriosus in small children weighing 10 kg or less. Korean J Pediatr 2010;53: 1012-7. https://doi.org/10.3345/kjp.2010.53.12.1012
  5. Prsa M, Ewert P. Transcatheter closure of a patent ductus arteriosus in a preterm infant with an Amplatzer Vascular Plug IV device. Catheter Cardiovasc Interv 2011;77:108-11. https://doi.org/10.1002/ccd.22657
  6. Balzer DT, Spray TL, McMullin D, Cottingham W, Canter CE. Endarteritis associated with a clinically silent patent ductus arteriosus. Am Heart J 1993;125:1192-3. https://doi.org/10.1016/0002-8703(93)90144-X
  7. Fortescue EB, Lock JE, Galvin T, McElhinney DB. To close or not to close: the very small patent ductus arteriosus. Congenit Heart Dis 2010;5:354-65. https://doi.org/10.1111/j.1747-0803.2010.00435.x
  8. Malnick SD, Shimoni S, Zimhony O. An unusual case of endocarditis. CMAJ 2006;174:1087-8. https://doi.org/10.1503/cmaj.051592
  9. Onji K, Matsuura W. Pulmonary endarteritis and subsequent pulmonary embolism associated with clinically silent patent ductus arteriosus. Intern Med 2007;46:1663-7. https://doi.org/10.2169/internalmedicine.46.0215
  10. Ozkokeli M, Ates M, Uslu N, Akcar M. Pulmonary and aortic valve endocarditis in an adult patient with silent patent ductus arteriosus. Jpn Heart J 2004;45:1057-61. https://doi.org/10.1536/jhj.45.1057
  11. Parthenakis FI, Kanakaraki MK, Vardas PE. Images in cardiology: silent patent ductus arteriosus endarteritis. Heart 2000;84:619. https://doi.org/10.1136/heart.84.6.619
  12. Satoh T, Nishida N. Patent ductus arteriosus with infective endocarditis at age 92. Intern Med 2008;47:263-8. https://doi.org/10.2169/internalmedicine.47.0445
  13. Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989;63:877-80. https://doi.org/10.1016/0002-9149(89)90064-7
  14. Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 2010;3:550-5.
  15. Ng B, Schneider DJ, Hokanson JS. Closure of tubular patent ductus arteriosus in infants and small children with the Amplatzer Vascular Plug II. Congenit Heart Dis 2011;6:64-9. https://doi.org/10.1111/j.1747-0803.2010.00466.x
  16. Ewert P. Challenges encountered during closure of patent ductus arteriosus. Pediatr Cardiol 2005;26:224-9. https://doi.org/10.1007/s00246-005-1010-8
  17. Hoyer MH. Novel use of the Amplatzer plug for closure of a patent ductus arteriosus. Catheter Cardiovasc Interv 2005;65:577-80. https://doi.org/10.1002/ccd.20347
  18. Cheatham JP. Not so fast with that Novel use: does AVP = PDA? Catheter Cardiovasc Interv 2005;65:581-3. https://doi.org/10.1002/ccd.20461
  19. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006;114:1873-82. https://doi.org/10.1161/CIRCULATIONAHA.105.592063

Cited by

  1. Closure of Tubular Patent Ductus Arteriosus With the Amplatzer Vascular Plug IV : Feasibility and Safety vol.6, pp.1, 2013, https://doi.org/10.1177/2150135114558070
  2. Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute vol.47, pp.4, 2017, https://doi.org/10.4070/kcj.2016.0311
  3. Transcatheter closure through single venous approach for young children with patent ductus arteriosus : A retrospective study of 686 cases vol.97, pp.35, 2013, https://doi.org/10.1097/md.0000000000011958